Table 3.

Donor-recipient mismatching at certain amino acid residues is permissive.

Mismatched HLA Locus	GVHD	Relapse	Survival
HLA-A	None identified22; Residue 9 [aGVHD23]	None identified22	None identified22
HLA-B	Residue 9 [cGVHD22]	None identified22	None identified22
HLA-C	Residue 116 [aGVHD22]; Residues 9, 77, 80, 99, 116, 156 [aGVHD23]	Residues 9, 99, 156 24	Residue 99 [TRM 22]
HLA-DPB1	TCE model [aGVHD9]	*GVL24; *TCE model9	No [GVH and GVL balanced9]

aGVHD, acute GVHD

cGVHD, chronic GVHD

^*Different eptiopes were tested^{9, 24}